Is the Cineworld share price too low ahead of results?

The Cineworld (LON:CINE) share price has done very well year-to-date. Could there be more to come in March?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Cineworld cinema

Image source: DCM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Cineworld (LSE: CINE) share price has climbed 20% in 2022 so far. Today, I’m asking whether this momentum can be sustained into next month and beyond.

Recovery in revenue

I’m actually not expecting all that much in the way of surprises when it comes to Cineworld’s full-year numbers on 17 March. After all, only a few weeks have passed since the company last provided an update on trading. 

In January, the battered mid-cap said performance and attendances had “steadily grown” over the six months to the end of December. In July 2021, for example, total revenue was 50% of what it had been in 2019. By the last month of 2021, this percentage had improved to 88%. Much of this increase can be attributed to popular releases such as Spider-Man: No Way Home, No Time to Die and Black Widow.

What’s far more important however, is how the company has traded so far this year. 

Cineworld share price: going higher?

On a positive note, the gradual (now complete) removal of Covid-19 restrictions over recent months can only be a good thing. Throw in the half-term holidays (and inevitably shocking British weather) and I reckon trading over the last couple of months has probably been solid, albeit not spectacular.

The slate of upcoming movies is also promising. A positive reaction from critics and fans to the new Batman film, for example, could help lift the Cineworld share price in advance of results day. Later in the year, we can expect sequels such as Top Gun 2 and Jurassic Park: Dominion.

Perhaps most importantly, there’s also been speculation in recent weeks that Cineworld will negotiate a deal with Canadian rival Cineplex over the former’s aborted deal to buy the latter. Agreeing to lower damages would actually be in Cineplex’s best interests. This is because it would receive very little (if anything) in the event of the business going bust. Avoiding bankruptcy would probably do no harm to the Cineworld share price either.

Red flags

Of course, lots of very rational arguments against investing in Cineworld remain. These include the reduced window between movie release dates and the same films being made available on streaming platforms. In fact, the rise in the cost of living also makes a monthly subscription to the latter look even better value for money than a trip to the flicks. 

Even if a deal is done with Cineplex, I also have to ask myself whether I’d want to own a stake in a company with such a horrific balance sheet. To be frank, there are so many far more robust businesses to choose from in the UK market.

20% up, but…

While the recent momentum might be welcome for those already holding the stock, we need to keep things in perspective. The Cineworld share price is still down 60% in the last 12 months. In the last five years, the company’s value has tumbled 86%.

I don’t think this pessimism is unjustified. And while there are certainly reasons for thinking that the stock could continue rising in March and beyond, I’m still not inclined to get on board even if it does.

If that means me missing out on the mother of all recoveries, so be it. The potential returns aren’t worth the stress of the journey, in my opinion. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »